CBOA
OPTR

Commonwealth Bank of Australia’s OPTIMER PHARMACEUTICALS, INC. COM STK OPTR Stock Holding History

Commonwealth Bank of Australia’s Portfolio OPTR Stock Details OPTR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q3 		– Sell
-10,240
Closed -$148K – 1358
2013
Q2 		$148K Buy
+10,240
New +$149K ﹤0.01% 1137

Other funds holding OPTR

WIC
Water Island Capital New York $896M AUM 107.59% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AAA
Alpine Associates Advisors Englewood Cliffs, New Jersey $158M AUM 48.85% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
DKCM
Davidson Kempner Capital Management New York $7.33B AUM 56.47% 1-Year Est. Return
JG
Jefferies Group New York $12B AUM 6.2% 1-Year Est. Return

Commonwealth Bank of Australia's OPTR Position: Q3 2013 in Review

Commonwealth Bank of Australia sold out of OPTIMER PHARMACEUTICALS, INC. COM STK (OPTR) in Q3 2013, closing a stake of 10,240 shares — an estimated $148K sold.

Commonwealth Bank of Australia first reported a position in OPTR in Q2 2013 and held it in 1 quarter. The position peaked at $148K in Q2 2013. 104 funds tracked by Wall St. Rank hold OPTR as of Q3 2013.

  • Commonwealth Bank of Australia reported no remaining OPTIMER PHARMACEUTICALS, INC. COM STK position as of Q3 2013 after selling out during the quarter.
  • Commonwealth Bank of Australia sold 10,240 OPTIMER PHARMACEUTICALS, INC. COM STK shares in Q3 2013, an estimated $148K.
  • Commonwealth Bank of Australia first reported a position in OPTIMER PHARMACEUTICALS, INC. COM STK in Q2 2013 and held it in 1 quarter.
  • Commonwealth Bank of Australia's OPTIMER PHARMACEUTICALS, INC. COM STK position peaked at $148K in Q2 2013.
  • 104 funds tracked by Wall St. Rank held OPTIMER PHARMACEUTICALS, INC. COM STK as of Q3 2013.

Based on Commonwealth Bank of Australia's 13F filing for Q3 2013, filed 5 Nov 2013.